Cambridge, Mass.-based Biogen will cut about 1,000 jobs as it plans to save $700 million by 2025, the company said July 25. 

As the U.S. drug industry waits to see how a Pfizer plant damaged by a tornado in North Carolina will affect their pharmaceutical supply, hospital pharmacy leaders have been experimenting with new ways to mitigate drug shortages. 

The U.S. now has an FDA-approved medication for a viral skin disease that afflicts 6 million people every year.

Walgreens has named Monica Reed, PharmD, as vice president of health centers strategy and operations, where she will oversee the company's 'Health Corners' clinics.

There will not be immediate or significant disruptions to the U.S. hospital drug market after a tornado hit a Pfizer plant in Rocky Mount, N.C., according to the FDA. 

Several Ohio CVS pharmacies are under investigation by the state pharmacy board for problems that led to thousands of controlled substances being lost and patient harm after a wrong medication was given, the Ohio Capital Journal reported July 24.

The Federal Trade Commission is backing away from its past advocacy statements for pharmacy benefit managers after a change in "current market realities."

The Massachusetts Medical Society and its Committee on Maternal and Perinatal Welfare voiced their support of the FDA's decision to permit sales of over-the-counter progestin-only birth control, according to a July 18 news release.

High demand has pushed another Novo Nordisk weight loss drug into shortage.

Severe winds from an EF-3 tornado on July 19 crushed a North Carolina Pfizer manufacturing plant that made nearly 25 percent of the drugmaker's sterile injectables used by U.S. hospitals.